Stephen L. Schmidt - Related publications

Psychiatry University of North Carolina, Chapel Hill, Chapel Hill, NC 
Networks , Pharmacology,
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Combes AJ, Courau T, Kuhn NF, Hu KH, Ray A, Chen WS, Chew NW, Cleary SJ, Kushnoor D, Reeder GC, Shen A, Tsui J, Hiam-Galvez KJ, Muñoz-Sandoval P, Zhu WS, ... , et al. Global absence and targeting of protective immune states in severe COVID-19. Nature. PMID 33494096 DOI: 10.1038/s41586-021-03234-7   
2021 Yordanova IA, Ebner F, Schulz AR, Steinfelder S, Rosche B, Bolze A, Paul F, Mei HE, Hartmann S. The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled Ova Immunotherapy. Life (Basel, Switzerland). 11. PMID 33572978 DOI: 10.3390/life11020101   
2021 Naidus E, Bouquet J, Oh DY, Looney TJ, Yang H, Fong L, Standifer NE, Zhang L. Early changes in the circulating T cells are associated with clinical outcomes after PD-L1 blockade by durvalumab in advanced NSCLC patients. Cancer Immunology, Immunotherapy : Cii. PMID 33420629 DOI: 10.1007/s00262-020-02833-z   
2021 Agresti N, Lalezari JP, Amodeo PP, Mody K, Mosher SF, Seethamraju H, Kelly SA, Pourhassan NZ, Sudduth CD, Bovinet C, ElSharkawi AE, Patterson BK, Stephen R, Sacha JB, Wu HL, et al. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. Journal of Translational Autoimmunity. 4: 100083. PMID 33521616 DOI: 10.1016/j.jtauto.2021.100083   
2021 Baird JH, Epstein DJ, Tamaresis JS, Ehlinger Z, Spiegel JY, Craig J, Claire GK, Frank MJ, Muffly L, Shiraz P, Meyer E, Arai S, Brown JW, Johnston L, Lowsky R, et al. Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma. Blood Advances. 5: 143-155. PMID 33570626 DOI: 10.1182/bloodadvances.2020002732   
2021 Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodríguez Y, Gallo JE, Salazar-Uribe JC, Santander MJ, Cala MP, Zapata W, Zapata MI, Manrique R, Pardo-Oviedo JM, Camacho B, Ramírez-Santana C, Anaya JM, , et al. COVID-19 convalescent plasma composition and immunological effects in severe patients. Journal of Autoimmunity. 118: 102598. PMID 33524876 DOI: 10.1016/j.jaut.2021.102598   
2021 Dominguez-Mozo MI, Perez-Perez S, Villarrubia N, Costa-Frossard L, Fernandez-Velasco JI, Ortega-Madueño I, Garcia-Martinez MA, Garcia-Calvo E, Estevez H, Luque Garcia JL, Torrejon MJ, Arroyo R, Villar LM, Alvarez-Lafuente R. Herpesvirus Antibodies, Vitamin D and Short-Chain Fatty Acids: Their Correlation with Cell Subsets in Multiple Sclerosis Patients and Healthy Controls. Cells. 10. PMID 33435197 DOI: 10.3390/cells10010119   
2021 Weijers JM, Müskens WD, van Riel PLCM. Effect of significant weight loss on disease activity: reason to implement this non-pharmaceutical intervention in daily clinical practice. Rmd Open. 7. PMID 33504577 DOI: 10.1136/rmdopen-2020-001498   
2021 Choueiri TK, Atkins MB, Rose TL, Alter RS, Ju Y, Niland K, Wang Y, Arbeit R, Parasuraman S, Gan L, McDermott DF. A phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy. Investigational New Drugs. PMID 33507454 DOI: 10.1007/s10637-020-01058-2   
2021 Islam MN, Dipi RM, Mostafa SN, Datta A. Progression of Disease in COVID-19 Patients Evaluated by Chest CT Imgaing and Correlated with Clinical Parameters. Mymensingh Medical Journal : Mmj. 30: 182-188. PMID 33397872   
2021 Giavedoni P, Martinez C, Podlipnik S, Suárez-Lleidó M, Martí-Martí I, Morgado-Carrasco D, Rovira M, Fernández-Avilés F, Gutiérrez G, Rosiñol L, Cid J, Lozano M, Mascaró JM. Assessment of Sclerodermoid Chronic Graft-versus-host Disease with Colour Doppler Ultrasound. Acta Dermato-Venereologica. PMID 33475145 DOI: 10.2340/00015555-3747   
2021 Chevrier S, Zurbuchen Y, Cervia C, Adamo S, Raeber ME, de Souza N, Sivapatham S, Jacobs A, Bachli E, Rudiger A, Stüssi-Helbling M, Huber LC, Schaer DJ, Nilsson J, Boyman O, et al. A distinct innate immune signature marks progression from mild to severe COVID-19. Cell Reports. Medicine. 2: 100166. PMID 33521697 DOI: 10.1016/j.xcrm.2020.100166   
2021 Sánchez RC, de la Fe AD, Suarez AP, Grass D, Vega TM, Canal AS, Siniscalco D, de Los Angeles Robinson Agramonte M. Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosis. Drug Development Research. PMID 33586209 DOI: 10.1002/ddr.21798   
2021 Kim Y, Kobayashi E, Suehara Y, Ito A, Kubota D, Tanzawa Y, Endo M, Nakatani F, Nakatsura T, Kawai A, Kaneko K, Kitano S. Immunological status of peripheral blood is associated with prognosis in patients with bone and soft-tissue sarcoma. Oncology Letters. 21: 212. PMID 33510813 DOI: 10.3892/ol.2021.12473   
2021 Meng T, Qi J, Zhu Y, Xu Y, Chen F, Xue S, Miao M, Chen S, Han Y, Tang X, Qiu H, Sun A, Wu D, Wang Y. Impact of disease status at allogeneic stem cell transplantation on adolescent and young adult patients with early T-cell precursor acute lymphoblastic leukemia. Hematological Oncology. PMID 33521954 DOI: 10.1002/hon.2841   
2021 Filser M, Baetge SJ, Balloff C, Buchner A, Fink GR, Heibel M, Meier U, Rau D, Renner A, Schreiber H, Ullrich S, Penner IK. Mental symptoms in MS (MeSyMS): Development and validation of a new assessment. Multiple Sclerosis and Related Disorders. 49: 102744. PMID 33517174 DOI: 10.1016/j.msard.2021.102744   
2021 Kim YJ, Kim SK, Jung TY, Kim IY, Lee KH, Moon KS. Inflammatory Brain Lesions as Omen of Primary Central Nervous System Lymphoma: A Case Report and Literature Review. Brain Sciences. 11. PMID 33557224 DOI: 10.3390/brainsci11020191   
2021 Li T, Wang X, Zhuang X, Wang H, Li A, Huang L, Zhang X, Xue Y, Wei F, Ma C. Baseline characteristics and changes of biomarkers in disease course predict prognosis of patients with COVID-19. Internal and Emergency Medicine. PMID 33565034 DOI: 10.1007/s11739-020-02560-4   
2021 Pereira NL, Ahmad F, Byku M, Cummins NW, Morris AA, Owens A, Tuteja S, Cresci S. COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine. Mayo Clinic Proceedings. 96: 446-463. PMID 33549263 DOI: 10.1016/j.mayocp.2020.11.024   
2021 Ferreiro Iglesias R, Barreiro-de Acosta M, López J, Bastón Rey I, Domínguez-Muñoz JE. USEFULNESS OF PERIPHERAL BLOOD MONOCYTE COUNT TO PREDICT RELAPSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE LONGITUDINAL COHORT STUDY. Revista Espanola De Enfermedades Digestivas : Organo Oficial De La Sociedad Espanola De Patologia Digestiva. PMID 33486959 DOI: 10.17235/reed.2021.7683/2020   
2021 Patrinely JR, McGuigan B, Chandra S, Fenton SE, Chowdhary A, Kennedy LB, Mooradian MJ, Palmeri M, Portal D, Horst SN, Scoville EA, Long GV, Shi C, Mehnert JM, Sullivan RJ, et al. A multicenter characterization of hepatitis associated with immune checkpoint inhibitors. Oncoimmunology. 10: 1875639. PMID 33628621 DOI: 10.1080/2162402X.2021.1875639   
2021 Eskelund CW, Dimopoulos K, Kolstad A, Glimelius I, Räty R, Gjerdrum LMR, Sonnevi K, Josefsson P, Nilsson-Ehle H, Bentzen HHN, Fagerli UM, Kuittinen O, Haaber J, Niemann CU, Pedersen LB, et al. Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3. Hemasphere. 5: e510. PMID 33364550 DOI: 10.1097/HS9.0000000000000510   
2021 Mondal E, Khan MM, Hossain MI, Moshwan MM, Saha R, Das SN, Moniruzzaman M. The Pattern of Lipid Profile in Patients with Chronic Kidney Disease. Mymensingh Medical Journal : Mmj. 30: 48-55. PMID 33397850   
2021 Moser SS, Bar J, Kan I, Ofek K, Cohen R, Khandelwal N, Shalev V, Chodick G, Siegelmann-Danieli N. Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes. Current Oncology (Toronto, Ont.). 28: 317-331. PMID 33435584 DOI: 10.3390/curroncol28010036   
2021 Qin S, Li W, Shi X, Wu Y, Wang C, Shen J, Pang R, He B, Zhao J, Qiao Q, Luo T, Guo Y, Yang Y, Han Y, Wu Q, et al. 3044 cases reveal important prognosis signatures of COVID-19 patients. Computational and Structural Biotechnology Journal. PMID 33584997 DOI: 10.1016/j.csbj.2021.01.042   
2021 Hu RW, Liu C, Gong JP, Cao ZX. Differential expression and immune correlation analysis of COVID-19 receptor ACE2 and TMPRSS2 genes in all normal and tumor tissues. European Review For Medical and Pharmacological Sciences. 25: 1724-1731. PMID 33629341 DOI: 10.26355/eurrev_202102_24882   
2021 Humby F, Durez P, Buch MH, Lewis MJ, Rizvi H, Rivellese F, Nerviani A, Giorli G, Mahto A, Montecucco C, Lauwerys B, Ng N, Ho P, Bombardieri M, Romão VC, ... , et al. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet (London, England). 397: 305-317. PMID 33485455 DOI: 10.1016/S0140-6736(20)32341-2   
2021 Carvalho V, Soares C, Gomes I, Carvalho A, Serrazina F, Rodrigues SG, Pinheiro J, Marques IB, Correia F, Correia AS, de Sá J, Sousa L, Vale J, Sá MJ, Sousa C, et al. RISCOP-Cognitive profile in a Portuguese cohort of radiological isolated syndrome patients: A case-control study. Multiple Sclerosis and Related Disorders. 50: 102832. PMID 33596492 DOI: 10.1016/j.msard.2021.102832   
2021 Hall EM, Yin DE, Goyal RK, Ahmed AA, Mitchell GS, St Peter SD, Flatt TG, Ahmed IA, Li W, Hendrickson RJ, August KJ, Myers GD. Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection. Journal For Immunotherapy of Cancer. 9. PMID 33472856 DOI: 10.1136/jitc-2020-001225   
2021 Wang D, Wang J, Hu G, Wang W, Xiao Y, Cai H, Jiang L, Meng L, Yang Y, Zhou X, Hong Z, Yao Z, Xiao M, Chen L, Mao X, et al. A Phase I Study of a Novel Fully Human BCMA-Targeting CAR (CT103A) in Patients with Relapsed/Refractory Multiple Myeloma. Blood. PMID 33512480 DOI: 10.1182/blood.2020008936   
2021 Chu M, Bian L, Huang J, Chen Y, Wu D, Wang H. Clinical characteristics and outcomes of 48 patients hospitalized for COVID-19 infection in Wuxi: A retrospective cohort study. Medicine. 100: e23991. PMID 33592854 DOI: 10.1097/MD.0000000000023991   
2021 Sheng JQ, Hu PJ, Liu X, Huang TS, Chen YH. Predictive Analytics for Care and Management of Patients With Acute Diseases: Deep Learning-Based Method to Predict Crucial Complication Phenotypes. Journal of Medical Internet Research. 23: e18372. PMID 33576744 DOI: 10.2196/18372   
2021 Somekh I, Lev A, Barel O, Lee YN, Hendel A, Simon AJ, Somech R. Exploring genetic defects in adults who were clinically diagnosed as severe combined immune deficiency during infancy. Immunologic Research. PMID 33599911 DOI: 10.1007/s12026-021-09179-3   
2021 Yue D, Qian J, Chen Z, Zhang B, Chen P, Zhang L, Li J, Zhang H, Wang C. Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with -rearranged lung adenocarcinoma. Journal For Immunotherapy of Cancer. 9. PMID 33558279 DOI: 10.1136/jitc-2020-001967   
2021 Samanci B, Sahin E, Bilgic B, Tufekcioglu Z, Gurvit H, Emre M, Demir K, Hanagasi HA. Neurological features and outcomes of Wilson's disease: a single-center experience. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 33474589 DOI: 10.1007/s10072-020-05013-0   
2021 Mohaghegh F, Moghaddasi M, Eslami M, Dadfar M, Lester D. Disability and its association with psychological factors in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 49: 102733. PMID 33571947 DOI: 10.1016/j.msard.2020.102733   
2021 Zhao X, Niu Q, Gan L, Hou FF, Liang X, Ni Z, Chen Y, Zhao J, Bieber B, Robinson B, Chen X, Zuo L. Baseline data report of the China Dialysis Outcomes and Practice Patterns Study (DOPPS). Scientific Reports. 11: 873. PMID 33441625 DOI: 10.1038/s41598-020-79531-4   
2021 Falck-Jones S, Vangeti S, Yu M, Falck-Jones R, Cagigi A, Badolati I, Österberg B, Lautenbach MJ, Ahlberg E, Lin A, Lepzien R, Szurgot I, Lenart K, Hellgren F, Maecker HT, et al. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity. The Journal of Clinical Investigation. PMID 33492309 DOI: 10.1172/JCI144734   
2021 Wang J, Zheng X, Chen J. Clinical progression and outcomes of 260 patients with severe COVID-19: an observational study. Scientific Reports. 11: 3166. PMID 33542448 DOI: 10.1038/s41598-021-82943-5   
2021 Atas B, Bulut M, Sap F, Yazar A, Akin F, Poyraz N, Tokgoz H. Paediatric systemic lupus erythematosus: A single referral centre experience. Jpma. the Journal of the Pakistan Medical Association. 71: 136-139. PMID 33484540 DOI: 10.5455/JPMA.61641   
2021 Xia F, Zhang M, Cui B, An W, Chen M, Yang P, Qin T, Zhou X, Liao Y, Xu X, Liu S, Li K, Zhou Q, Wang K, Hu G, et al. COVID-19 patients with hypertension are at potential risk of worsened organ injury. Scientific Reports. 11: 3779. PMID 33580165 DOI: 10.1038/s41598-021-83295-w   
2021 Chen Z, Tan YJ, Lian MM, Tandiono M, Foo JN, Lim WK, Kandiah N, Tan EK, Ng ASL. High Diagnostic Utility Incorporating a Targeted Neurodegeneration Gene Panel With MRI Brain Diagnostic Algorithms in Patients With Young-Onset Cognitive Impairment With Leukodystrophy. Frontiers in Neurology. 12: 631407. PMID 33597917 DOI: 10.3389/fneur.2021.631407   
2021 Ekmekyapar T, Ozcan C, Ciftci O. Relationships of total leukocyte, neutrophil and lymphocyte levels with the menstrual cycle in patients receiving fingolimod treatment. European Review For Medical and Pharmacological Sciences. 25: 447-454. PMID 33506935 DOI: 10.26355/eurrev_202101_24413   
2021 Jenkins PM, Al Daoud F, Mercer L, Scholten D, Wong K, Perinjelil V, Majeski K, Cranford J, Elian G, Nigam T, Carto CA, Sachwani-Daswani GR. The Presence of Nucleated Red Blood Cells as an Indicator for Increased Mortality and Morbidity in Burn Patients. Journal of Burn Care & Research : Official Publication of the American Burn Association. PMID 33608722 DOI: 10.1093/jbcr/irab035   
2021 Wang X, Zhang X, Yu U, Wang C, Yang C, Li Y, Li C, Wen F, Li C, Liu S. Co-Transplantation of Haploidentical Stem Cells and a Dose of Unrelated Cord Blood in Pediatric Patients with Thalassemia Major. Cell Transplantation. 30: 963689721994808. PMID 33593080 DOI: 10.1177/0963689721994808   
2021 Alkrenawi M, Osherov M, Simonovich A, Droujin J, Milo R, Appel S. Association between cervical disc disease and lesions of multiple sclerosis. The Neuroradiology Journal. 1971400920983565. PMID 33393859 DOI: 10.1177/1971400920983565   
2021 How JA, Jazaeri A, Westin SN, Sood AK, Ramondetta LM, Xu M, Abonofal A, Karp DD, Subbiah V, Stephen B, Rodon JA, Yang F, Naing A. The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial. Investigational New Drugs. PMID 33415580 DOI: 10.1007/s10637-020-01043-9   
2021 Ma T, Wiggins CC, Kornatowski BM, Hailat RS, Clayburn AC, Guo W, Johnson PW, Senefeld JW, Klassen SA, Baker SE, Bruno KA, Fairweather D, Wright RS, Carter RE, Li C, et al. The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma. Medrxiv : the Preprint Server For Health Sciences. PMID 33501470 DOI: 10.1101/2021.01.19.21249678   
2021 Büttner L, Bauknecht HC, Fleckenstein FN, Kahn J, Tietze A, Bohner G, Siebert E. Neuroimaging Findings in Conjunction with Severe COVID-19. Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin. PMID 33535257 DOI: 10.1055/a-1345-9784   
2021 Thebault S, Bose G, Booth R, Freedman MS. Serum neurofilament light in MS: The first true blood-based biomarker? Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458521993066. PMID 33565908 DOI: 10.1177/1352458521993066